Esperion Therapeutics, Inc.
Head of Investor Relations
Head of Investor Relations
Esperion Therapeutics, Inc.
Analyst
Corporate Communications
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Ben Church is recorded as Head of Investor Relations at Esperion Therapeutics, Inc. and Analyst at Corporate Communications. Ben Church has spoken on 3 earnings calls across 1 company, most recently for Esperion Therapeutics, Inc. on January 11, 2022.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Esperion Therapeutics, Inc.
Head of Investor Relations
Source not stated
Corporate Communications
Analyst
Source not stated
Recorded roles and call appearances connecting this person to public companies.
Esperion Therapeutics, Inc.
Head of Investor Relations
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
Esperion Therapeutics, Inc. Q4 FY2021 Earnings Call
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. Q3 FY2021 Earnings Call
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. Q2 FY2021 Earnings Call
Esperion Therapeutics, Inc.